Dimed S.A. Distribuidora de MedicamentosBMFBOVESPA: PNVL3

Dimed: Disciplined omnichannel growth, proprietary brands, and digital innovation drive sustained value

· Issued by Dimed S.A. Distribuidora de Medicamentos

A disciplined growth strategy aims to double revenue by 2025 and again by 2030, leveraging omnichannel excellence, proprietary brands, and digital innovation. Strong financial discipline, customer loyalty, and operational efficiency underpin sustained market share gains and margin expansion.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Dimed S.A. Distribuidora de Medicamentos on 6ix

Earlier from Dimed S.A. Distribuidora de Medicamentos

Later from Dimed S.A. Distribuidora de Medicamentos

All Dimed S.A. Distribuidora de Medicamentos news releases